Medical Properties Trust (MPT) vs. Its Rivals Head-To-Head Contrast

Medical Properties Trust (NYSE:MPT) is one of 90 publicly-traded companies in the “Real Estate Investment Trusts” industry, but how does it contrast to its peers? We will compare Medical Properties Trust to related businesses based on the strength of its risk, analyst recommendations, dividends, earnings, valuation, profitability and institutional ownership.

Insider & Institutional Ownership

71.8% of Medical Properties Trust shares are owned by institutional investors. Comparatively, 63.7% of shares of all “Real Estate Investment Trusts” companies are owned by institutional investors. 1.3% of Medical Properties Trust shares are owned by insiders. Comparatively, 7.9% of shares of all “Real Estate Investment Trusts” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Medical Properties Trust has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Medical Properties Trust’s peers have a beta of 1.15, suggesting that their average share price is 15% more volatile than the S&P 500.

Dividends

Medical Properties Trust pays an annual dividend of $0.36 per share and has a dividend yield of 6.3%. Medical Properties Trust pays out -78.3% of its earnings in the form of a dividend. As a group, “Real Estate Investment Trusts” companies pay a dividend yield of 4.0% and pay out 102.7% of their earnings in the form of a dividend. Medical Properties Trust is clearly a better dividend stock than its peers, given its higher yield and lower payout ratio.

Profitability

This table compares Medical Properties Trust and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Properties Trust	-28.50%	-5.83%	-1.85%
Medical Properties Trust Competitors	-34.14%	-18.20%	-0.23%

Analyst Ratings

This is a breakdown of recent recommendations for Medical Properties Trust and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Properties Trust	1	0	1	0	2.00
Medical Properties Trust Competitors	2346	4059	2396	22	2.01

Medical Properties Trust presently has a consensus target price of $8.00, suggesting a potential upside of 38.89%. As a group, “Real Estate Investment Trusts” companies have a potential upside of 17.37%. Given Medical Properties Trust’s higher possible upside, analysts plainly believe Medical Properties Trust is more favorable than its peers.

Valuation & Earnings

This table compares Medical Properties Trust and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Medical Properties Trust	$972.02 million	-$277.05 million	-12.52
Medical Properties Trust Competitors	$463.71 million	$16.35 million	26.54

Medical Properties Trust has higher revenue, but lower earnings than its peers. Medical Properties Trust is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Medical Properties Trust beats its peers on 9 of the 15 factors compared.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT’s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.